Anya is a young, agile and innovative publicly listed (TWO: 7776) pharmaceutical company founded in Taipei, Taiwan with offices in India and the United States. Our core mission is to be the authority in oral delivery of peptides. Our patented technology platform Mira/Je® is a flexible solution easy to adapt to a large variety of peptides. Mira/Je® has shown delivery of therapeutic amount in a number of clinical and preclinical studies in a variety of peptides such as teriparatide, leuprorelin, octreotide, semaglutide, liraglutide, tirzepatide and insulin glargine.
The management team has extensive experience in the pharmaceutical industry with average 20 years in development and commercialization of biologics and small molecules.
Our guiding principles are Excellence, Engagement and Efficiency.